Fluorescent in situ hybridization on tissue microarrays: challenges and solutions
- 10 January 2007
- journal article
- review article
- Published by Springer Nature in Journal of Molecular Histology
- Vol. 38 (2) , 151-157
- https://doi.org/10.1007/s10735-006-9069-y
Abstract
Tissue microarray (TMA) technology has provided a high throughput means of evaluating potential biomarkers and therapeutic targets in archival pathological specimens. TMAs facilitate the rapid assessment of molecular alterations in hundreds of different tumours on a single slide. Sections from TMAs can be used for any in situ tissue analysis, including fluorescent in situ hybridization (FISH). FISH is a molecular technique that detects numerical and structural abnormalities in both metaphase chromosomes and interphase nuclei. FISH is commonly used as a prognostic and diagnostic tool for the detection of translocations and for the assessment of gene deletion and amplification in tumours. Performing FISH on TMAs enables researchers to determine the clinical significance of specific genetic alterations in hundreds of highly characterized tumours. The use of FISH on archival paraffin embedded tissues is technically demanding and becomes even more challenging when applied to paraffin embedded TMAs. The problems encountered with FISH on TMAs, including probe preparation, hybridization, and potential applications of FISH, will be addressed in this review.Keywords
This publication has 25 references indexed in Scilit:
- Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with RearrangementNeoplasia, 2006
- Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomasGynecologic Oncology, 2006
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosisOncogene, 2005
- Assessment of Her-1, Her-2, and Her-3 Expression and Her-2 Amplification in Advanced Stage Ovarian CarcinomaInternational Journal of Gynecological Pathology, 2005
- A fluorescence in situ hybridization study of ETV6‐NTRK3 fusion gene in secretory breast carcinomaGenes, Chromosomes and Cancer, 2004
- EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian CancerCell, 2003
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase IJournal of Molecular Biology, 1977